At SCOR, we are pushing back the frontiers of insurability by insuring people who were previously excluded from insurance protection.

This publication presents some global information on kidney diseases, the definitions and basic notions, protective treatments, renal replacement therapies, disease progression information as well as proposed underwri

SOLEM supports our clients throughout the world to assess risks, including a dedicated Claims management section.

The growing use of economic-value-based metrics will greatly benefit longstanding reinsurers, writes Denis Kessler, Chairman and CEO of SCOR, for the CEO Forum

At its annual Investor Day in Paris, SCOR presents its new strategic plan, “Quantum Leap”.